Page last updated: 2024-11-04

sulfinpyrazone and Bronchospasm

sulfinpyrazone has been researched along with Bronchospasm in 2 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butler, KD1
Smith, JR1
Szczeklik, A1
Czerniawska-Mysik, G1
Nizankowska, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Outcome Impact of Different Tranexamic Acid Regimen in Cardiac Surgery With Cardiopulmonary Bypass (the OPTIMAL Study)[NCT03782350]Phase 43,079 participants (Actual)Interventional2018-12-26Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for sulfinpyrazone and Bronchospasm

ArticleYear
Mechanisms of Forssman-induced bronchospasm and their inhibition.
    British journal of pharmacology, 1981, Volume: 73, Issue:1

    Topics: Animals; Aspirin; Blood Platelets; Bronchial Spasm; Complement System Proteins; Forssman Antigen; Gu

1981
Sulfinpyrazone and aspirin-induced asthma.
    The New England journal of medicine, 1980, Sep-18, Volume: 303, Issue:12

    Topics: Anaphylaxis; Aspirin; Asthma; Bronchial Spasm; Dipyrone; Drug Hypersensitivity; Humans; Sulfinpyrazo

1980